Company ShanXi C&Y Pharmaceutical Group Co.,LTD.

Company ShanXi C&Y Pharmaceutical Group Co.,LTD.

300254

CNE1000016D0

Pharmaceuticals

Equities

300254

CNE1000016D0

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Pharmaceuticals

SHANXI C&Y PHARMACEUTICAL GROUP CO.,LTD.

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
9.29 ^CNY	-1.90%		-3.43%	-3.53%

Apr. 12	ShanXi C&Y Pharmaceutical Group Co.,LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 18	ShanXi C&Y Pharmaceutical Group Co.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

ShanXi C&Y Pharmaceutical Group Co., Ltd. is principally engaged in the research, development, manufacture and distribution of pharmaceuticals. The Companyâs main products include anti-infective agents, respiratory system agents, cardiovascular drugs, antidepressant drugs, urinary system agents, pediatric agents and other drugs, as well as pharmaceutical raw materials and pharmaceutical intermediates. It also involves in the manufacture and distribution of health food products, as well as the provision of deoxyribonucleic acid (DNA) genetic preservation and pregnant environment testing services. The Company distributes its products in domestic market.

CNY in Million	2022	Weight	2023	Weight	Delta
Anti-infective Drugs 22.2 %	173	20.9 %	177	22.2 %	+2.23%
Urinary System Drugs 20.7 %	129	15.5 %	165	20.7 %	+28.39%
Other Medicines 17.0 %	119	14.4 %	136	17.0 %	+13.61%
Pediatric Use 8.4 %	70	8.4 %	67	8.4 %	-3.42%
Anti-allergy 8.3 %	166	20.1 %	66	8.3 %	-60.22%
Respiratory Medicine 7.2 %	39	4.7 %	58	7.2 %	+47.77%
Pharmaceutical Raw Materials and Intermediates 7.1 %	46	5.6 %	57	7.1 %	+22.82%
Service 3.3 %	34	4.1 %	27	3.3 %	-20.84%
Kidney Medicine 3.3 %	37	4.5 %	26	3.3 %	-29.20%
Health Food 1.6 %	11	1.3 %	13	1.6 %	+16.91%
Other Business 0.9 %	4	0.5 %	7	0.9 %	+65.81%
Commercial 0.1 %	0	0.1 %	1	0.1 %	+71.18%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	807	97.3 %	799	100.0 %	-0.93%
Hong Kong 0.0 %	22	2.7 %	0	0.0 %	-99.09%

Managers	Title	Age	Since
Qun Zhao CEO	Chief Executive Officer	53	05-02-28
Yan Jie He DFI	Director of Finance/CFO	42	10-11-30
Hai Rong Zhong BRD	Director/Board Member	65	15-03-16
Jun Xian Yu BRD	Director/Board Member	57	05-02-28
Xu Hong Zhang BRD	Director/Board Member	53	05-02-28
Yuan Yuan Xue IRC	Investor Relations Contact	-	-
Ying Min Yu PRN	Corporate Officer/Principal	61	16-07-06

Members of the board	Title	Age	Since
Qun Zhao CEO	Chief Executive Officer	53	05-02-28
Xu Hong Zhang BRD	Director/Board Member	53	05-02-28
Jun Xian Yu BRD	Director/Board Member	57	05-02-28
Hai Rong Zhong BRD	Director/Board Member	65	15-03-16
Hao Gao BRD	Director/Board Member	54	20-02-10
Le Qun Huang CHM	Chairman	69	20-01-31
Tao Ju BRD	Director/Board Member	38	20-02-10

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	241,618,563	46,676,925 ( 19.32 %)	0	19.32 %

Name	Equities	%	Valuation
China Asset Management Co., Ltd. 0.4606 %	632,700	0.4606 %	786 345 ¥
Western Leadbank Fund Management Co., Ltd 0.2341 %	321,600	0.2341 %	399 697 ¥
Manulife TEDA Fund Management Co., Ltd. 0.0714 %	98,100	0.0714 %	121 923 ¥
Lion Fund Management Co., Ltd. 0.0127 %	17,400	0.0127 %	21 625 ¥
Gfund Management Co., Ltd. 0.000146 %	200	0.000146 %	249 ¥

Shanxi C&Y Pharmaceutical Group Co., Ltd.

1378, Heng'an Street Economic & Technological Dev Zone

037010, Datong

http://www.cy-pharm.com

address ShanXi C&Y Pharmaceutical Group Co.,LTD.(300254)

	1st Jan change	Capi.
SHANXI C&Y PHARMACEUTICAL GROUP CO.,LTD.	-3.53%	316M
NOVO NORDISK A/S	+31.37%	588B
JOHNSON & JOHNSON	-3.08%	364B
MERCK & CO., INC.	+19.57%	326B
ABBVIE INC.	+5.19%	285B
ASTRAZENECA PLC	+14.83%	239B
NOVARTIS AG	+9.93%	210B
ROCHE HOLDING AG	-6.95%	200B
AMGEN INC.	+10.66%	167B
PFIZER, INC.	+0.50%	161B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals